Magazine article from our research archive:
|
|
Bristol-Myers Squibb to Acquire Kosan Biosciences for 10.33 Times Revenue
- Article from:
-
Weekly Corporate Growth Report
- Article date:
-
June 2, 2008
- Author:
-
|
Copyright informationCopyright NVST, Inc. Jun 2, 2008. Provided by ProQuest LLC. (Hide copyright information)
|
The Deal: Bristol-Myers Squibb Company has entered into a definitive agreement to purchase Kosan Biosciences Inc. for $5.50 per share in a cash tender offer. Under the terms of the agreement, if a majority of Kosan shares are tendered, Bristol-Myers will acquire the remaining untendered shares for $5.50 per share. Bristol-Myers estimates the transaction value at approximately $190 million after the deduction of Kosan's projected net cash balance at June 30, 2008, when the deal is expected to close. The deal has been unanimously approved by the boards of both companies. Kosan has also agreed not to solicit competing offers for the company.
Discussion: Kosan Biosciences is a development-stage ...
Related newspaper, magazine, and journal articles:
|
Bristol-Myers Squibb Finalizes Purchase of Kosan Biosciences.
Health & Beauty Close-Up;
June 29, 2008 ;
217 words
......CLOSE-UP-29 June 2008-Bristol-Myers Squibb Finalizes Purchase of Kosan Biosciences(C)2008 - CloseUpMedia...newsdesk@closeupmedia.com Bristol-Myers Squibb Company announced...million acquisition of Kosan Biosciences Inc. As a result of...wholly-owned ...
|
|
Small Cap Stock Winners - LMLG, KOSN, ULBI, TRMP.
M2 Presswire;
May 30, 2008 ;
700+ words
......52 week low of $0.07. Bristol-Myers Squibb Company (NYSE: BMY) and Kosan Biosciences Inc. (Nasdaq: KOSN) Closed...for the acquisition of Kosan, a cancer therapeutics company, by Bristol-Myers Squibb, for $5.50 per share...epothilones. What They Do: Kosan ...
|
|
|
Kosan Biosciences Inc Added to Bellwether Watch List.
M2 Presswire;
December 20, 2006 ;
700+ words
......Biotech News: Kosan Biosciences Inc Added to Bellwether...RDATE:20122006 Kosan Biosciences Inc (NASDAQ:KOSN...Volume: 410,872 Kosan Biosciences Inc Added to Bellwether...List(NASDAQ:KOSN) Kosan Biosciences is manipulative...cholesterol fighter from ...
|
|
|
Current Research on Kosan Biosciences Inc.
M2 Presswire;
January 26, 2007 ;
700+ words
......Current Research on Kosan Biosciences Inc(C)1994-2007...Current Research on Kosan Biosciences Inc (NASDAQ:KOSN) Kosan Biosciences is manipulative...cholesterol fighter from Bristol-Myers Squibb. Kosan targets infectious...date information on Kosan ...
|
|
|
Fundamental Review for Kosan Biosciences Inc.
M2 Presswire;
January 10, 2007 ;
700+ words
......Fundamental Review for Kosan Biosciences Inc(C)1994-2007...Fundamental Review for Kosan Biosciences Inc (NASDAQ:KOSN) Kosan Biosciences is manipulative...cholesterol fighter from Bristol-Myers Squibb. Kosan targets infectious...date information on ...
|
|
|
In-Depth Research on Kosan Biosciences Inc.
M2 Presswire;
January 8, 2007 ;
700+ words
......In-Depth Research on Kosan Biosciences Inc(C)1994-2007...In-Depth Research on Kosan Biosciences Inc (NASDAQ:KOSN) Kosan Biosciences is manipulative...cholesterol fighter from Bristol-Myers Squibb. Kosan targets infectious...date information on Kosan ...
|
|
Kosan Biosciences to Present at June Healthcare Conferences.
PR Newswire;
May 27, 2005 ;
388 words
......May 27 /PRNewswire-FirstCall/ -- Kosan Biosciences today announced that Daniel V. Santi...completed for two weeks. About Kosan Kosan Biosciences has two first-in-class anticancer...diseases. For additional information on Kosan Biosciences, please visit the Company's website...
|
|
|
Kosan Biosciences to Present at the Susquehanna Second Annual SIGnificant...
PR Newswire;
February 29, 2008 ;
324 words
......Feb. 29 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated announced today that...available for two weeks. About Kosan Kosan Biosciences is a biotechnology company advancing...GERD). For additional information on Kosan Biosciences, please visit the company's website...
|
|
|
Kosan Biosciences to Present at Healthcare Conferences.
PR Newswire;
March 23, 2005 ;
409 words
......March 23 /PRNewswire-FirstCall/ -- Kosan Biosciences today announced that Robert G. Johnson...completed for two weeks. About Kosan Kosan Biosciences has two first-in-class anticancer...diseases. For additional information on Kosan Biosciences, please visit the Company's website...
|
|
|
Progress Review For Kosan Biosciences Inc.
M2 Presswire;
December 11, 2007 ;
700+ words
......streetinvesting.com: Progress Review For Kosan Biosciences Inc(C)1994-2007 M2 COMMUNICATIONS...meeting on Tuesday. Looking into the Kosan Biosciences Inc (NASDAQ:KOSN) was trading up...various prospective companies therein. Kosan Biosciences Inc. was among those that we have...
|
|
|
Kosan Biosciences to Present at the Cowen and Company 28th Annual Health...
PR Newswire;
March 14, 2008 ;
334 words
......March 14 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated announced today that...available for two weeks. About Kosan Kosan Biosciences is a biotechnology company advancing...GERD). For additional information on Kosan Biosciences, please visit the company's website...
|
See all results.
Or, try our
Advanced Search.
|